Literature DB >> 8081135

Variation in coverage by ethnic group of neonatal (Guthrie) screening programme in south London.

A Streetly1, C Grant, G Bickler, P Eldridge, S Bird, W Griffiths.   

Abstract

OBJECTIVES: To determine whether coverage of the neonatal (Guthrie) screening programme in Britain is different for groups at highest risk of sickle cell disease and to identify possible reasons for incomplete coverage.
DESIGN: Descriptive study of coverage of screening programme and its variation by mobility, district of residence, and ethnic group.
SUBJECTS: 1727 infants born between 1 October and 31 December 1991.
SETTING: Former West Lambeth and Camberwell District Health Authorities, London. MAIN OUTCOME MEASURE: Proportion of infants with an identifiable screening test result.
RESULTS: Screening covered 1663/1727 (96.3%) infants overall (745/786 (94.8%) in West Lambeth; 918/941 (97.6%) in Camberwell). The relative odds ratio of an African infant not having been tested compared with a white infant was 3.05 (95% confidence interval 1.30 to 7.14) (2.08 (0.86 to 5.01) after adjustment for mobility and district of residence). For infants whose families moved into the districts after the birth compared with those born and resident in the districts the relative odds ratio of having been tested was 10.16 (4.85 to 21.29). The odds ratio of locally delivered infants in West Lambeth not having been tested compared with those in Camberwell was 2.12 (1.08 to 4.16) after adjustment for ethnic group.
CONCLUSION: Coverage of the screening programme is incomplete and poorer in infants of African ethnic group than in white infants. Poorer coverage is also associated with mobility of the family around the time of birth. The findings have implications for using the neonatal programme for testing for sickle cell disease and other disorders. Arrangements for monitoring the existing screening programme are inadequate and an improved system should be established, similar to the scheme that monitors the immunisation programme.

Entities:  

Mesh:

Year:  1994        PMID: 8081135      PMCID: PMC2541192          DOI: 10.1136/bmj.309.6951.372

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  Audit of screening for congenital hypothyroidism.

Authors:  P O Pharoah; M P Madden
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

2.  Review of neonatal screening programme for phenylketonuria.

Authors:  D Elliman; J Garner
Journal:  BMJ       Date:  1991-08-24

Review 3.  Effectiveness of newborn screening programs for congenital hypothyroidism: prevalence of missed cases.

Authors:  D A Fisher
Journal:  Pediatr Clin North Am       Date:  1987-08       Impact factor: 3.278

4.  Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing.

Authors:  A E Ades; S Parker; T Berry; F J Holland; C F Davison; D Cubitt; M Hjelm; A H Wilcox; C N Hudson; M Briggs
Journal:  Lancet       Date:  1991-06-29       Impact factor: 79.321

5.  Sickle cell disease: the case for coordinated information.

Authors:  A Streetly; M Dick; M Layton
Journal:  BMJ       Date:  1993-06-05

6.  Neonatal screening.

Authors:  R J Pollitt
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

7.  Loophole in U.K. screening programme for P.K.U.

Authors:  J M Rattenbury; J K Brown
Journal:  Lancet       Date:  1978-08-26       Impact factor: 79.321

8.  Congenital hypothyroidism: increased risk of neonatal morbidity results in delayed treatment.

Authors:  P M Fernhoff; A L Brown; L J Elsas
Journal:  Lancet       Date:  1987-02-28       Impact factor: 79.321

9.  Review of neonatal screening programme for phenylketonuria.

Authors:  I Smith; B Cook; M Beasley
Journal:  BMJ       Date:  1991-08-10

10.  Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism.

Authors:  J L Dhondt; J P Farriaux; J C Sailly; T Lebrun
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

  10 in total
  7 in total

1.  Survey of scope of neonatal screening in the United Kingdom.

Authors:  A Streetly; C Grant; R J Pollitt; G M Addison
Journal:  BMJ       Date:  1995-09-16

2.  Audit of neonatal screening programme for phenylketonuria and congenital hypothyroidism.

Authors:  N Simpson; R Randall; S Lenton; S Walker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

3.  Neonatal screening. Performance is hard to monitor.

Authors:  F P Cappuccio; M Hickman; M Barker
Journal:  BMJ       Date:  1996-01-20

4.  Audit improves neonatal (Guthrie) screening programme.

Authors:  A Galloway; J Stevenson
Journal:  BMJ       Date:  1994-10-01

5.  Impact of incomplete coverage of neonatal dried blood spot screening on estimating HIV-1 seroprevalence.

Authors:  E J Hutchinson; A Streetly; C Grant; R Pollitt; P Eldridge; A Nicoll
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

6.  Coverage of neonatal screening: failure of coverage or failure of information system.

Authors:  A E Ades; J Walker; R Jones; I Smith
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

7.  Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7.

Authors:  A Streetly; R Latinovic; K Hall; J Henthorn
Journal:  J Clin Pathol       Date:  2009-01       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.